Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1675-1679, 2003; 10.1373/49.10.1675
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmieri, O.
Right arrow Articles by Fortina, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmieri, O.
Right arrow Articles by Fortina, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2003;49:1675-1679.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

CARD15 Genotyping in Inflammatory Bowel Disease Patients by Multiplex Pyrosequencing

Orazio Palmieri1,2, Stephen Toth3, Alessandro Ferraris4,5,6, Angelo Andriulli2, Anna Latiano2, Vito Annese2, Bruno Dallapiccola4,5,6, Maurizio Vecchi7, Marcella Devoto8,9, Saul Surrey1 and Paolo Fortina1,a

1 Department of Medicine, Thomas Jefferson University, Jefferson Medical College, Philadelphia, PA 19104

2 Unita’di Ricerca in Gastroenterologia, IRCCS Casa Sollievo della Sofferenza, I-71013 San Giovanni Rotondo, Italy

3 Pyrosequencing, Inc., Westborough, MA 01581

4 IRCCS C.S.S., I-71013 San Giovanni Rotondo, Italy

5 C.S.S.-Mendel, 00161 Rome, Italy

6 Dipartimento di Medicina Sperimentale e Patologia, Universitá "La Sapienza", 00161 Rome, Italy

7 Istituto e Servizio di Gastroenterologia, IRCCS Ospedale Maggiore e Universitá di Milano, 20122 Milan, Italy

8 Department of Biomedical Research, Nemours Children’s Clinic, Wilmington, DE 19880

9 Dipartimento di Oncologia, Biologia e Genetica, Universitá di Genova, 16146 Genoa, Italy

aaddress correspondence to this author at: 406 Medical Office Bldg., 1100 Walnut St., Philadelphia, PA 19107; fax 215-955-6905, e-mail paolo.fortina@jefferson.edu

The first 300 words of the full text of this article appear below.

We describe here a method for detection of three common single-nucleotide polymorphisms (SNPs) in the inflammatory bowel disease (IBD)-related CARD15 gene. We used a two-step approach with multiplex PCR and pyrosequencing. Although the three loci are spaced far from one another, the built-in multiplexing capability of pyrosequencing reactions to extend for numerous bases was used with appropriate primers and the design of efficient deoxynucleoside triphosphate (dNTP) dispensation orders to screen for the variants simultaneously.

IBDs are chronic relapsing disorders affecting the gastrointestinal tract with a population prevalence in Western countries of 1:1000 (1). The complex trait is subdivided on the basis of clinical and histologic features into two main subtypes: Crohn disease (CD) and ulcerative colitis (UC) (2)(3)(4)(5). Whereas UC is limited to the rectal and colonic mucosal layers, CD can involve any part of the intestine, most frequently the terminal ileum and colon (6)(7)(8)(9). Several candidate loci for IBD have been identified on the basis of whole-genome scans in different populations (10)(11)(12)(13)(14)(15)(16)(17)(18). Of these, the one on chromosome 16 named IBD1 has been confirmed in several independent studies (11)(12)(15)(16)(17)(18). Three SNPs in the CARD15 gene, located in the IBD1 region, have been demonstrated to confer susceptibility to CD, but not to UC, in several populations and to correlate with an ileal site of the disease (6)(7)(8)(9)(10).

In this report, using a previously described approach for SNP/mutation analysis (19), we developed and validated a protocol to characterize simultaneously the R702W . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
CVIHome page
C. A. A. van der Graaf, M. G. Netea, B. Franke, S. E. Girardin, J. W. M. van der Meer, and B. J. Kullberg
Nucleotide Oligomerization Domain 2 (Nod2) Is Not Involved in the Pattern Recognition of Candida albicans.
Clin. Vaccine Immunol., March 1, 2006; 13(3): 423 - 425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. L. Roberts, R. B. Gearry, M. D.E. Allington, H. R. Morrin, B. A. Robinson, and F. A. Frizelle
Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer.
Cancer Res., March 1, 2006; 66(5): 2532 - 2535.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Verri, F. Focher, G. Tettamanti, and V. Grazioli
Two-Step Genetic Screening of Thrombophilia by Pyrosequencing
Clin. Chem., July 1, 2005; 51(7): 1282 - 1284.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.